Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil after one-night CPAP withdrawal in obstructive sleep apnea
ACTRN12606000005550Phase 3Completed
- Sponsor
- Woolcock Institute of Medical Research
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of modafinil in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Woolcock Institute of Medical Research. Primary endpoints: Lane deviation during driving simulator task, Reaction time to divided attention probes and 1 more. Started Jan 2006; status: completed.
02
Drugs
modafinil
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12606000005550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000005550.